1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Global Rapid Medical Diagnostic Kits Market - Applications and Technologies

The global market for Rapid Medical Diagnostic Kits (MDKs) has been witnessing steady, albeit not rapidly accelerated, growth over the past few years, and this trend is likely to sustain over the coming years. One of the major factors that can be attributed to this is the quick time, typically inside of 30 minutes, within which test results can be made available. This helps physicians in expediting the therapy process for individuals by prescribing the appropriate medications within a short period of time. Gone are the days when doctors had to rely on out-of-office laboratories, which more often than not took days, if not weeks, in processing and providing test results. Now, a clinical test using a sample from the patient can be performed within a physician’s office, the specimen sent to an in-house laboratory and results obtained while the patient waits.

Rapid Medical Diagnostic Kits have also been finding increasing applications in home-based settings, more so in the areas of blood glucose testing/monitoring and pregnancy testing, with several companies offering easy-to-use home-based tests for a range of purposes. Developing regions of the world, such as countries in Asia-Pacific and South America, are taking the lead in home-based Rapid Medical Diagnostic Kits due to the convenience offered by them. Growing disposable incomes in these regions have led to rapid lifestyle changes among the population, which has been causing the onset of lifestyle diseases, such as diabetes. For instance, it is not feasible for an individual with diabetes, who has to undergo constant testing and monitoring for ascertaining her/his blood sugar levels on a daily basis, to make repeated trips to a clinic or hospital. Instead, she/he can self-perform the test using a home blood glucose monitoring kit within the four walls of her/his home and obtain the results within a matter of minutes, which can be conveyed to the physician for determining if any alteration in therapy is required.

Worldwide market for Rapid Medical Diagnostic Kits application segments explored in this study includes Clinical Testing, Home-Based Testing and Veterinary Testing. These broader application segments further analyzed for the applications areas of Blood Glucose, Cholesterol, Fertility & Pregnancy, Infectious Disease and Substance Abuse. The report also focuses on the technologies of Rapid Medical Diagnostic Kits comprising Agglutination, Flow-Through, Lateral Flow and Solid-Phase. The global markets for the above mentioned application segments and diagnostic technologies are analyzed in terms of USD. Global market for Rapid Medical Diagnostic Kits, estimated at US$19.4 billion in 2014, forecast at US$20.4 billion in 2015 and further expected to maintain a CAGR of 5.7% between 2014 and 2020 to reach a projected US$27 billion by 2020.

This report reviews, analyses and projects the Rapid Medical Diagnostic Kits market for global and the regional markets including North America, Europe, Asia-Pacific, South America and Rest of World. The regional markets further analyzed for 14 independent countries across North America – The United States, Canada and Mexico; Europe – France, Germany, Italy, Spain and the United Kingdom; Asia-Pacific –China, India, Japan and South Korea; South America – Argentina and Brazil.

This 510 page market research report includes 290 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of market numbers. This report profiles 42 key global players and 55 major players across North America – 39; Europe – 7; and Asia-Pacific – 9. The research also provides the listing of the companies engaged in manufacturing and supply of Rapid MDKs. The global list of companies covers addresses, contact numbers and the website addresses of 193 companies.

Table Of Contents

Global Rapid Medical Diagnostic Kits Market - Applications and Technologies
TABLE OF CONTENTS:

PART A: GLOBAL MARKET PERSPECTIVE

1. INTRODUCTION
1.1 Product Outline
1.1.1 Rapid Diagnostic Tests
1.1.1.1 The Principle of Rapid Diagnostic Tests
1.1.1.2 Proper Utilization of Rapid Diagnostic Tests
1.1.1.2.1 Economics of Rapid Diagnostic Kits
1.1.1.2.2 Obstacles to the Wider Adoption of Rapid Diagnostic Tests: The “Three As”
1.1.2 Application Areas of Rapid Medical Diagnostic Tests
1.1.2.1 Blood Glucose Testing
1.1.2.2 Cholesterol Testing
1.1.2.3 Fertility and Pregnancy Testing
1.1.2.3.1 Male Fertility Test
1.1.2.3.2 Female Fertility Test
1.1.2.3.3 Pregnancy Test
1.1.2.4 Infectious Disease Testing
1.1.2.5 Substance Abuse Testing
1.1.2.5.1 Period of Detection
1.1.2.5.2 Techniques of Substance Abuse Testing
1.1.3 Technologies of Rapid Medical Diagnostic Test Kits
1.1.3.1 Agglutination Tests
1.1.3.1.1 Performing an Agglutination Assay
1.1.3.2 Flow-Through Tests
1.1.3.2.1 Performing a Flow-Through-Based Assay
1.1.3.3 Lateral Flow Tests
1.1.3.3.1 Components of a Lateral Flow Test
1.1.3.3.2 The Working of a Lateral Flow Test
1.1.3.3.3 Benefits and Drawbacks of Lateral Flow Tests
1.1.3.3.4 Applications of Lateral Flow Tests in Various Areas
1.1.3.4 Solid-Phase Tests
1.1.3.4.1 The Working of a Solid-Phase Test
1.1.3.5 A Summing Up of Advantages and Disadvantages of Rapid Diagnostic Tests and their Technologies
1.1.3.6 Rapid Diagnostic Tests for Neglected Tropical Diseases

2. KEY MARKET TRENDS
2.1 Blood Glucose Testing Market Propelled by Incidence of Diabetes
2.2 Lateral Flow Technology Dominates
2.3 A Rapid DNA Test for Replacing PCR?
2.4 A Host of Next-Generation Malaria Tests in the Offing
2.5 Paper Test Under Development for Ebola
2.6 Diagnostics-in-a-Suitcase for Detecting Ebola Virus
2.7 Infectious Disease Diagnostics Made Easier through Saliva Test Kit
2.8 Diagnosing Dengue through Rapid Immunoglobulin M-Based Test Using Surface Plasmon Resonance Biosensor
2.9 Portable Lab for Quick and Inexpensive Diagnosis Revolutionizes RDTs Market
Detection of Cocaine Consumption
Colon Cancer Monitoring
2.10 Rapid HIV Testing Gaining Acceptance in Dental Settings
2.11 Challenges and Potential of Malaria Rapid Diagnostic Tests
2.12 Electronic Chip for Rapid and Consistent Pathogen Identification
2.13 Efforts of Eradicating Malaria Get a Shot in the Arm
2.14 Rapid Detection of Tuberculosis Enabled through a Test Approved by WHO
2.15 Novel Rapid and Point-of-Care Tests for Hepatitis C Offer Immense Potential
2.16 Rapid Detection of H5N1 Facilitated through Novel Test Kit
2.17 Quicker Disease Diagnosis with Innovative Single Virus Detection Techniques

3. KEY GLOBAL PLAYERS

4. KEY BUSINESS TRENDS
Commercial Release of BioSURE HIV Self Test in the UK to Detect HIV Antibodies
Bill and Melinda Gates Foundation Selects Chembio for Developing a DPP® Malaria POC Rapid Diagnostic Test
USDA Approves Abaxis' VetScan FeLV-FIV Rapid Test Kit to Detect FeLV Antigen and FIV Antibodies
Launch of Bio-Rad's ddPCRâ„¢ KRAS Screening Multiplex Kit
Fast-track diagnostics introduces Real-time PCR Kit to Detect the Zaire Ebola Virus
Release of QuantiFERON®-TB Gold Plus from QIAGEN to Detect TB Infections
Roche Receives Emergency Use Authorization from FDA for its LightMix Ebola Zaire rRT-PCR Test
The Gates and Allen Foundations Offers New Grants to Corgenix for Expediting the Development of an Ebola Rapid Diagnostic Test Kit
Launch of SPOTCHEMâ„¢ i-Line FluAB-S Influenza Virus Kit by ARKRAY
US FDA Grants CLIA Waiver for Trinity Biotech's Syphilis Health Check
QIAGEN and altona Diagnostics Form Pact to Distribute FDA-authorized RealStar® Ebolavirus RT-PCR Kit 1.0
FDA Grants Clearance for Cepheid's Xpert® Norovirus in vitro Diagnostic Test
Thermo Fisher and Samsung Partner to Offer New POC Diagnostic Solutions to Healthcare Industry
Chembio Develops DPP® Technology-based Multiplex POC Influenza Immunity Test
FDA Grants Clearance for InBios International's CL Detectâ„¢ Rapid Test
The Allen and Gates Foundations Offers Grant to Cepheid to Develop Xpert Ebola Rapid Test
BBI Solutions Enters into a License Agreement with Genisphere to Develop Lateral Flow Rapid Test Applications
Development of a 60-Second Rapid Diagnostic Test by bioLytical to Detect Ebola Zaire Strain Antibodies
Chembio Signs Two Individual Deals for Developing POC Diagnostic Tests for Dengue Fever Virus and a Type of Cancer
Establishment of Hainan Savy Akers Biosciences for Marketing Rapid Diagnostic Screening and Testing Products in China
Thermo Fisher Scientific's New Ion PGM Dx System Receives CE-IVD Mark
Configuration of NanoLogix's N-Assay Rapid Diagnostic Kits to Detect and Identify Ebolavirus and Enterovirus
QuickNaviâ„¢-Flu Rapid Diagnostic Test Kit Provided with "Know with AR! Influenza" App to Reinforce the Provision of Diagnosis-related Information
MedMira, Beacon Biomedical Join Forces for Rapid Colon Cancer Test Development
Alere Achieves CE Mark for Marketing New E. HISTOLYTICA QUIK CHEKâ„¢ Test
Launch of ADAMS A1c mini Glycated-Hemoglobin Analyzer by ARKRAY
Introduction of a New SERELISA® ParaTB Ab Mono Indirect Assay Kit by Zoetis
Trinity's Meritas BNP Test Receives CE Mark
Debut of Malaria Rapid Diagnostic Test Kits in the UNITAID Private Sector
Commercial Launch of Cepheid's Xpert® TV in Europe for Rapid Identification of Trichomoniasis Infections
New Adrenocortocotropic Hormone ELISA Kit Launched by Epitope Diagnostics
Corgenix Collaborates with VHFC to Develop an Ebola Rapid Diagnostic Test Kit
Launch of Zoetis' On-farm Cattle Health Screening Tests for the Dairy Industry in China
Lumora Completes the Development of Buccal Swab DNA Extraction Kit
USDA Approves VetScan Canine Ehrlichia Antibody Test Kit for Use in Rapid Detection of Canine Ehrlichia
NIH Grants $2.9 million to Corgenix for Developing an Ebola Raid Diagnostic Test Kit
BioPlex 2200 HIV Ag-Ab Kit Introduced by Bio-Rad for Early detection of HIV
Commercial Launch of CE-IVD Marked Xpert® Carba-R by Cepheid
OraSure Signs a Master Program Services and Co-Promotion Agreement with AbbVie
Release of Two New CE-IVD Labeled DNA Mutation Detection Kits for Cystic Fibrosis and Familial Mediterranean Fever
ARKRAY to Launch SPOTCHEM i-Pack Oxystress Test
Launch of New Reveal® 2.0 for PSP by Neogen
Beckman Coulter Introduces Prostate Health Index to the US Market
Release of Cepheid's Xpert Norovirus In Vitro Diagnostic Test to Rapidly Detect and Differentiate Noroviruses GI and GII
FDA Grants Clearance for Meridian Bioscience's New Molecular Diagnostic Test for B. pertussis
BD Diagnostics Receives US FDA Clearance and CLIA Waiver for BD Veritorâ„¢ System for Rapid Detection of RSV
ARKRAY to Launch the i-densy Pack UGT1A1 (*28/*6) to Detect UDP Glucuronyl Transferase
Commercial Accessibility of Alere i Influenza A and B Test in Europe
Core Diagnostics Debuts ovaCORE, cerviCORE, hemaCORE, and neuroCORE Cancer Diagnostics Tests in India
New Soleris® DLA-109 Vial Developed by Neogen for Rapid and Accurate Detection of Lactic Acid-Producing Microorganisms
Chembio Receives First Purchase Order for DPP® HIV-Syphilis Assay from Mexico
Commercial Launch of Alere Determineâ„¢ HIV-1/2 Ag/Ab Combo Test in the United States
Debut of bioMerieux's Parvovirus B19 R-gene® Kit to identify and measure three Parvovirus B19 Genotypes
Alere Broadens the Impact of New Test Target Treatâ„¢ Campaign Website
Atomo Diagnostics to Debut of AtomoRapidâ„¢ Malaria Testing Kit in Durban
New FDA-Proposed Performance Standards for RIDTs Supported by BD
Introduction of New OncoScanâ„¢ FFPE Assay Kit by Affymetrix
Launch of Bio-Rad's QX200 Droplet Digital PCR System
CE-Marked ß-Hydroxybutyrate Strip Test Introduced by EKF Diagnostics
Exosome diagnostics Join Forces with QIAGEN to Develop and Commercialize Molecular Diagnostic Test Kits to Capture and Process RNA and DNA from Biofluids
European Release of Diagenode's Bordetella Pertussis and Parapertussis Real-Time PCR Kit for BD Diagnostics' BD MAX System
TB Biosciences to Develop More Accurate Diagnostic test for Tuberculosis
Corgenix to Present New Diagnostic Test Kits at AACC Clinical Lab Expo 2013
New Version of xTAG CYP2D6 Kit Attains FDA and CE Clearance
Corgenix Signs Multi-Year Contract with EDP Biotech to Launch the ColoMarkerâ„¢ Diagnostic Test
Commercialization of AtomoRapidâ„¢, a Convenient, Hand-held Rapid Blood Test Device
Veredus and A*STAR Association Brings in VereChip
EKF Presents Strip-based Anemia Determination Test at ISBT
Promising New Biomarkers from QIAGEN
Corgenix Associates with Eli Lilly to Develop Oncology Concerned Diagnostic Technology
ARKRAY Announces a Fully-Automatic Urine Analyzer with Additional Features
A complete Lipid Panel testing system from ACON
Bill and Melinda Gates Foundation funds Alere Inc. new developments

5. GLOBAL MARKET OVERVIEW
5.1 Global Rapid Medical Diagnostic Kits Market Overview by Application Segment
5.1.1 Global Clinical Testing Market Overview by Application Area
5.1.2 Global Home-Based Testing Market Overview by Application Area
5.1.3 Rapid MDKs Application Segment Market Overview by Geographic Region
5.1.3.1 Clinical Testing
5.1.3.1.1 Clinical Testing Application Area Market Overview by Geographic Region
5.1.3.1.1.1 Blood Glucose
5.1.3.1.1.2 Cholesterol
5.1.3.1.1.3 Fertility and Pregnancy
5.1.3.1.1.4 Infectious Disease
5.1.3.1.1.5 Substance Abuse
5.1.3.2 Home-Based Testing
5.1.3.2.1 Home-Based Testing Application Area Market Overview by Geographic Region
5.1.3.2.1.1 Blood Glucose
5.1.3.2.1.2 Cholesterol
5.1.3.2.1.3 Fertility and Pregnancy
5.1.3.2.1.4 Infectious Disease
5.1.3.2.1.5 Substance Abuse
5.1.3.3 Veterinary Testing
5.2 Global Rapid Medical Diagnostic Kits Market Overview by Technology
5.2.1 Rapid MDKs Technology Market Overview by Geographic Region
5.2.1.1 Agglutination Assay-Based
5.2.1.2 Flow-Through Assay-Based
5.2.1.3 Lateral Flow Assay-Based
5.2.1.4 Solid-Phase Assay-Based

PART B: REGIONAL MARKET PERSPECTIVE

REGIONAL MARKET OVERVIEW

1. NORTH AMERICA
1.1 North American Rapid MDKs Market Overview by Region
1.2 North American Rapid MDKs Market Overview by Application Segment
1.2.1 North American Clinical Testing Market Overview by Application Area
1.2.2 North American Home-Based Testing Market Overview by Application Area
1.2.3 Rapid MDKs Application Segment Market Overview by NA Region
1.2.3.1 Clinical Testing
1.2.3.2 Home-Based Testing
1.2.3.3 Veterinary Testing
1.3 North American Rapid MDKs Market Overview by Technology
1.3.1 Rapid MDKs Technology Market Overview by NA Region
1.3.1.1 Agglutination Assay-Based
1.3.1.2 Flow-Through Assay-Based
1.3.1.3 Lateral Flow Assay-Based
1.3.1.4 Solid-Phase Assay-Based
1.4 Major Market Players

1.5 North American Rapid MDKs Market Overview by Country
1.5.1 The United States
1.5.1.1 Rapid MDKs Market Overview by Application Segment
1.5.1.1.1 Clinical Testing Market Overview by Application Area
1.5.1.1.2 Home-Based Testing Market Overview by Application Area
1.5.1.2 Rapid MDKs Market Overview by Technology

1.5.2 Canada
1.5.2.1 Rapid MDKs Market Overview by Application Segment
1.5.2.1.1 Clinical Testing Market Overview by Application Area
1.5.2.1.2 Home-Based Testing Market Overview by Application Area
1.5.2.2 Rapid MDKs Market Overview by Technology

1.5.3 Mexico
1.5.3.1 Rapid MDKs Market Overview by Application Segment
1.5.3.1.1 Clinical Testing Market Overview by Application Area
1.5.3.1.2 Home-Based Testing Market Overview by Application Area
1.5.3.2 Rapid MDKs Market Overview by Technology

2. EUROPE
2.1 European Rapid MDKs Market Overview by Region
2.2 European Rapid MDKs Market Overview by Application Segment
2.2.1 European Clinical Testing Market Overview by Application Area
2.2.2 European Home-Based Testing Market Overview by Application Area
2.2.3 Rapid MDKs Application Segment Market Overview by European Region
2.2.3.1 Clinical Testing
2.2.3.2 Home-Based Testing
2.2.3.3 Veterinary Testing
2.3 European Rapid MDKs Market Overview by Technology
2.3.1 Rapid MDKs Technology Market Overview by European Region
2.3.1.1 Agglutination Assay-Based
2.3.1.2 Flow-Through Assay-Based
2.3.1.3 Lateral Flow Assay-Based
2.3.1.4 Solid-Phase Assay-Based
2.4 Major Market Players
Biomerieux SA (France)
Diasorin S.p.A. (Italy)
EKF Diagnostics Holdings Plc (United Kingdom)
F. Hoffmann-La Roche Ltd (Switzerland)
Labsystems Diagnostics OY (Finland)
Siemens Healthcare (Germany)
Trinity Biotech Plc (Ireland)

2.5 European Rapid MDKs Market Overview by Country
2.5.1 France
2.5.1.1 Rapid MDKs Market Overview by Application Segment
2.5.1.1.1 Clinical Testing Market Overview by Application Area
2.5.1.1.2 Home-Based Testing Market Overview by Application Area
2.5.1.2 Rapid MDKs Market Overview by Technology

2.5.2 Germany
2.5.2.1 Rapid MDKs Market Overview by Application Segment
2.5.2.1.1 Clinical Testing Market Overview by Application Area
2.5.2.1.2 Home-Based Testing Market Overview by Application Area
2.5.2.2 Rapid MDKs Market Overview by Technology

2.5.3 Italy
2.5.3.1 Rapid MDKs Market Overview by Application Segment
2.5.3.1.1 Clinical Testing Market Overview by Application Area
2.5.3.1.2 Home-Based Testing Market Overview by Application Area
2.5.3.2 Rapid MDKs Market Overview by Technology

2.5.4 Spain
2.5.4.1 Rapid MDKs Market Overview by Application Segment
2.5.4.1.1 Clinical Testing Market Overview by Application Area
2.5.4.1.2 Home-Based Testing Market Overview by Application Area
2.5.4.2 Rapid MDKs Market Overview by Technology

2.5.5 The United Kingdom
2.5.5.1 Rapid MDKs Market Overview by Application Segment
2.5.5.1.1 Clinical Testing Market Overview by Application Area
2.5.5.1.2 Home-Based Testing Market Overview by Application Area
2.5.5.2 Rapid MDKs Market Overview by Technology

2.5.6 Rest of Europe
2.5.6.1 Rapid MDKs Market Overview by Application Segment
2.5.6.1.1 Clinical Testing Market Overview by Application Area
2.5.6.1.2 Home-Based Testing Market Overview by Application Area
2.5.6.2 Rapid MDKs Market Overview by Technology

3. ASIA-PACIFIC
3.1 Asia-Pacific Rapid MDKs Market Overview by Region
3.2 Asia-Pacific Rapid MDKs Market Overview by Application Segment
3.2.1 Asia-Pacific Clinical Testing Market Overview by Application Area
3.2.2 Asia-Pacific Home-Based Testing Market Overview by Application Area
3.2.3 Rapid MDKs Application Segment Market Overview by Asia-Pacific Region
3.2.3.1 Clinical Testing
3.2.3.2 Home-Based Testing
3.2.3.3 Veterinary Testing
3.3 Asia-Pacific Rapid Medical Diagnostic Kits Market Overview by Technology
3.3.1 Rapid MDKs Technology Market Overview by Asia-Pacific Region
3.3.1.1 Agglutination Assay-Based
3.3.1.2 Flow-Through Assay-Based
3.3.1.3 Lateral Flow Assay-Based
3.3.1.4 Solid-Phase Assay-Based
3.4 Major Market Players
Atlas Link Biotech Co., Ltd (China)
Atomo Diagnostics Pty Limited (Australia)
Biocare Diagnostics, Ltd. (China)
KEE Gad Biogen Pvt. Ltd. (India)
Rapid Diagnostic Pvt. Ltd. (India)
Runbio Biotech Co., Ltd. (China)
Shanghai Kehua Bio-Engineering Co., Ltd (KHB) (China)
Standard Diagnostics, Inc (South Korea)
Taidoc Technology Corporation (Taiwan)

3.5 Asia-Pacific Rapid MDKs Market Overview by Country
3.5.1 China
3.5.1.1 Rapid MDKs Market Overview by Application Segment
3.5.1.1.1 Clinical Testing Market Overview by Application Area
3.5.1.1.2 Home-Based Testing Market Overview by Application Area
3.5.1.2 Rapid MDKs Market Overview by Technology

3.5.2 India
3.5.2.1 Rapid MDKs Market Overview by Application Segment
3.5.2.1.1 Clinical Testing Market Overview by Application Area
3.5.2.1.2 Home-Based Testing Market Overview by Application Area
3.5.2.2 Rapid MDKs Market Overview by Technology

3.5.3 Japan
3.5.3.1 Rapid MDKs Market Overview by Application Segment
3.5.3.1.1 Clinical Testing Market Overview by Application Area
3.5.3.1.2 Home-Based Testing Market Overview by Application Area
3.5.3.2 Rapid MDKs Market Overview by Technology

3.5.4 South Korea
3.5.4.1 Rapid MDKs Market Overview by Application Segment
3.5.4.1.1 Clinical Testing Market Overview by Application Area
3.5.4.1.2 Home-Based Testing Market Overview by Application Area
3.5.4.2 Rapid MDKs Market Overview by Technology

3.5.5 Rest of Asia-Pacific
3.5.5.1 Rapid MDKs Market Overview by Application Segment
3.5.5.1.1 Clinical Testing Market Overview by Application Area
3.5.5.1.2 Home-Based Testing Market Overview by Application Area
3.5.5.2 Rapid MDKs Market Overview by Technology

4. SOUTH AMERICA
4.1 South American Rapid MDKs Market Overview by Region
4.2 South American Rapid MDKs Market Overview by Application Segment
4.2.1 South American Clinical Testing Market Overview by Application Area
4.2.2 South American Home-Based Testing Market Overview by Application Area
4.2.3 Rapid MDKs Application Segment Market Overview by SA Region
4.2.3.1 Clinical Testing
4.2.3.2 Home-Based Testing
4.2.3.3 Veterinary Testing
4.3 South American Rapid MDKs Market Overview by Technology
4.3.1 Rapid MDKs Technology Market Overview by NA Region
4.3.1.1 Agglutination Assay-Based
4.3.1.2 Flow-Through Assay-Based
4.3.1.3 Lateral Flow Assay-Based
4.3.1.4 Solid-Phase Assay-Based

4.4 South American Rapid MDKs Market Overview by Country
4.4.1 Argentina
4.4.1.1 Rapid MDKs Market Overview by Application Segment
4.4.1.1.1 Clinical Testing Market Overview by Application Area
4.4.1.1.2 Home-Based Testing Market Overview by Application Area
4.4.1.2 Rapid MDKs Market Overview by Technology

4.4.2 Brazil
4.4.2.1 Rapid MDKs Market Overview by Application Segment
4.4.2.1.1 Clinical Testing Market Overview by Application Area
4.4.2.1.2 Home-Based Testing Market Overview by Application Area
4.4.2.2 Rapid MDKs Market Overview by Technology

4.4.3 Rest of South America
4.4.3.1 Rapid MDKs Market Overview by Application Segment
4.4.3.1.1 Clinical Testing Market Overview by Application Area
4.4.3.1.2 Home-Based Testing Market Overview by Application Area
4.4.3.2 Rapid MDKs Market Overview by Technology

5. REST OF WORLD
5.1 Rapid MDKs Market Overview by Application Segment
5.1.1 Clinical Testing Market Overview by Application Area
5.1.2 Home-Based Testing Market Overview by Application Area
5.2 Rapid MDKs Market Overview by Technology

PART C: GUIDE TO THE INDUSTRY
1. NORTH AMERICA
2. EUROPE
3. ASIA-PACIFIC
4. REST OF WORLD

PART D: ANNEXURE
1. RESEARCH METHODOLOGY
2. FEEDBACK

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.